-
MIGRAINE BURDEN OF ILLNESS AMONG A COMMERCIALLY INSURED US POPULATION (IFORM-I)
Feb 25, 2026, 14:43 PM -
ESTIMATING STATE- AND COUNTY-LEVEL CHRONIC DISEASE AND RISK FACTOR PREVALENCE: VALIDATING A SYNTHETIC POPULATION APPROACH USING NATIONALLY REPRESENTATIVE SURVEY DATA
Feb 25, 2026, 14:43 PM -
INDIVIDUAL PICO REVIEW AND HIERARCHY IN SYSTEMATIC LITERATURE REVIEWS: WHY GUIDELINE ADHERENCE MATTERS AND HOW REAL-SLRS REDUCE REWORK
Feb 25, 2026, 14:43 PM -
REPRESENTATIVENESS OF LINKED CLAIMS-EHR DATA: CLAIMS-ONLY VS CLAIMS+EHR POPULATIONS
Feb 25, 2026, 14:43 PM -
TIMING OF SERIOUS ADVERSE EVENTS FOLLOWING MIFEPRISTONE ABORTION IN US COMMERCIAL AND MEDICAID POPULATIONS
Feb 25, 2026, 14:43 PM -
COMPARATIVE ANALYSIS OF RISK FACTORS AND SHORT-TERM OUTCOMES AFTER PRIMARY PCI IN PRE- AND POST-MENOPAUSAL WOMEN WITH STEMI EXPERIENCE FROM LMIC
Feb 25, 2026, 14:43 PM -
PREDICTORS OF ANTIDEPRESSANT SWITCH AND ASSOCIATED COSTS IN MAJOR DEPRESSIVE DISORDER: A PROSPECTIVE STUDY FROM A TERTIARY-CARE HOSPITAL IN INDIA
Feb 25, 2026, 14:43 PM -
EXPLORING THE RELATIONSHIP BETWEEN HEALTH-RELATED SOCIAL NEEDS AND CHRONIC DISEASE AMONG JEFFERSON HEALTH PATIENTS
Feb 25, 2026, 14:43 PM -
PERFORMANCE OF AI METHODS FOR TITLE/ABSTRACT SCREENING: COMPARING CRITERIA-BASED AND ADVANCEMENT PROBABILITY-BASED SCREENING APPROACHES
Feb 25, 2026, 14:43 PM -
COMPARING COST-EFFECTIVENESS RESULTS AND IMPLEMENTATION CHARACTERISTICS OF IDENTICAL SHORT-TERM CEAS ACROSS MODELING PLATFORMS
Feb 25, 2026, 14:43 PM -
ACCEPTABILITY, PERCEPTIONS, AND BARRIERS TO VASECTOMY ACCESS IN LATIN AMERICA: A SYSTEMATIC REVIEW INFORMING POLICY AND HEALTH SYSTEM ACTION
Feb 25, 2026, 14:43 PM -
SYSTEMATIC LITERATURE REVIEW OF PROGNOSTIC FACTORS AND TREATMENT EFFECT MODIFIERS IN NON-MUSCLE INVASIVE BLADDER CANCER
Feb 25, 2026, 14:43 PM -
EVALUATING THE ASSOCIATION BETWEEN SURROGATE ENDPOINTS AND LIVER-RELATED OUTCOMES IN PRIMARY BILIARY CHOLANGITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Feb 25, 2026, 14:43 PM -
INCLUSION OF PATIENT-REPORTED OUTCOME MEASURES FOR PEDIATRIC VERSUS ADULT POPULATIONS IN FDA BIOLOGICAL AND NOVEL DRUG THERAPY APPROVALS FROM 2021-2025
Feb 25, 2026, 14:43 PM -
PATIENT-REPORTED EXPERIENCES WITH CANCER-RELATED FATIGUE (CRF) FOLLOWING TREATMENT WITH CAR T-CELL THERAPY (CAR-T) IN PATIENTS WITH LYMPHOMA OR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Feb 25, 2026, 14:43 PM -
COST-UTILITY ANALYSIS OF [177LU]PSMA THERAPY COMPARED TO CABAZITAXEL IN PATIENTS WITH MCRPC FROM THE PERSPECTIVE OF THE COLOMBIAN HEALTH SYSTEM
Feb 25, 2026, 14:43 PM -
SOCIODEMOGRAPHIC DISPARITIES IN DIAGNOSTIC DISCORDANCE BETWEEN RADIOLOGISTS AND A COMMERCIAL AI ALGORITHM FOR PULMONARY EMBOLISM (PE) DETECTION
Feb 25, 2026, 14:43 PM -
PRESERVING VISION AND PRODUCTIVITY: THE SOCIAL IMPACT OF INNOVATIVE DME THERAPY IN CHILE (2017-2032)
Feb 25, 2026, 14:43 PM -
AUTOMATING MODEL PARAMETERISATION FOR HEALTH ECONOMIC MODELS: VALIDATION OF A GEN-AI RAG PIPELINE
Feb 25, 2026, 14:43 PM -
PATIENT-MODIFIABLE RISK FACTORS FOR ANASTOMOTIC LEAK IN COLORECTAL SURGERY: A SCOPING REVIEW
Feb 25, 2026, 14:43 PM
